Subsequent Event (Details) - USD ($) $ / shares in Units, $ in Millions |
Aug. 01, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|---|
| Subsequent Event [Line Items] | |||
| Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | |
| Subsequent Event | |||
| Subsequent Event [Line Items] | |||
| Common stock, par value (in dollars per share) | $ 0.001 | ||
| Subsequent Event | Invidior Pharmaceuticals, Inc. | Acquisition Term Loan | Unsecured Debt | |||
| Subsequent Event [Line Items] | |||
| Commitments to extend credit | $ 650 | ||
| Subsequent Event | Supernus Pharmaceuticals, Inc. | Invidior Pharmaceuticals, Inc. | |||
| Subsequent Event [Line Items] | |||
| Business combination, share exchange ratio | 1.5401 | ||
| One-time special cash dividend | $ 1,000 |